BridgeMD
New treatment option for Meniscus Tear
Official title The Effect of Therapeutic Exercise on Cartilage Morphology and Physical Function for Individuals at High Risk of Knee Osteoarthritis
ClinicalTrials.gov ID: NCT06532851
What this study is testing
- What it's testing
- This randomized controlled trial aims to evaluate the efficacy of progressive resistance exercises (PRE) versus aerobic exercises on cartilage morphology and physical function in patients with degenerative meniscus tears. 45 participants, aged 35-55, will be randomly assigned to one of three groups: PRE, aerobic exercise, or control (standard of care physical and medical therapy).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 55. Healthy volunteers may be eligible.
You may be able to join if
- Are between 35 and 55 years of age.
- Have a symptomatic degenerative medial meniscus tear as evidenced by:
- Presence of medial knee pain.
- Medial joint line tenderness.
- Pain and limited motion when attempting to perform a full squat and
You likely can't join if
- Radiographic evidence of OA (K-L grade 2 or above).
- A repairable meniscus injury (longitudinal tear in the outer 1/3 of the meniscus).
- A meniscus injury that requires meniscectomy (locked knee).
- Prior or current ligament injury or surgery of the involved knee.
- Prior or current injury or surgery to contra-lateral knee.
- Pathological ligamentous laxity upon examination of the knee
See the full eligibility criteria
- Are between 35 and 55 years of age.
- Have a symptomatic degenerative medial meniscus tear as evidenced by:
- Presence of medial knee pain.
- Medial joint line tenderness.
- Pain and limited motion when attempting to perform a full squat and
- Increased intra-meniscal signal on at least 2 consecutive MRI slices and
- Have clearance from their personal physician to participate in an exercise program.
- Radiographic evidence of OA (K-L grade 2 or above).
- A repairable meniscus injury (longitudinal tear in the outer 1/3 of the meniscus).
- A meniscus injury that requires meniscectomy (locked knee).
- Prior or current ligament injury or surgery of the involved knee.
- Prior or current injury or surgery to contra-lateral knee.
- Pathological ligamentous laxity upon examination of the knee
- An inflammatory arthritic condition or
- Any injury or condition involving the lower extremities that affects their ability to walk. Because participation in this study requires undergoing MRI, people will be excluded if they:
- If female, pregnant at the time of enrollment.
- Had prior surgery for an aneurysm; any medical illness that may interfere with the patient's general fitness or exercise capability.
- Had any contraindication with MRI.
- Had surgery within the past two months.
- Have a cardiac pacemaker.
The study team makes the final eligibility decision.
Where it's taking place
- Ar Ramtha, Jordan
- Irbid, Jordan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ar Ramtha, Jordan; Irbid, Jordan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.